Literature DB >> 1539630

Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia.

E M Gallant1, L R Lentz.   

Abstract

A defect in the skeletal muscle sarcoplasmic reticulum (SR) calcium release channel of malignant hyperthermia-susceptible (MHS) pigs greatly enhances SR calcium release in pigs homozygous for the malignant hyperthermia (MH) gene. In pigs heterozygous at this locus, rates of calcium release from isolated SR stimulated by Ca2+, ATP, or caffeine are intermediate to those of both MHS and normal SR [Mickelson et al. Am. J. Physiol. 257 (Cell Physiol. 26): C787-C794, 1989]. In this study bundles of intact muscle cells dissected from pigs of various genotypes were used to examine the effects of the MH gene on contractile responses to caffeine (direct stimulation of the SR) or to surface membrane (sarcolemma) depolarization (i.e., stimulation by way of the steps in excitation-contraction coupling). The caffeine threshold for contractures in the heterozygous muscles (5 mM) was intermediate to both types of homozygous muscles (2 mM for MHS and 10 mM for normal) as is the case with direct stimulation of calcium release from SR vesicles [Mickelson et al. Am. J. Physiol. 257 (Cell Physiol. 26): C787-C794, 1989]. Sarcolemmal depolarization was elicited by electrical stimuli or elevated extracellular potassium. Control twitch tension for MHS and heterozygous muscles did not differ and was significantly greater in both than in homozygous normal muscles. Potassium-induced contractures were significantly larger in MHS and heterozygous than in normal muscles. Thus, in heterozygous muscles, force production via sarcolemmal depolarization (twitches and potassium contractures) was enhanced as much as in homozygous MHS muscles. This could be the result of feedback from abnormal SR calcium channels producing altered (enhanced) transverse tubule to SR signal transduction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1539630     DOI: 10.1152/ajpcell.1992.262.2.C422

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2001-09       Impact factor: 4.086

2.  Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.

Authors:  B Dietze; J Henke; H M Eichinger; F Lehmann-Horn; W Melzer
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

3.  A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.

Authors:  Eric Estève; José M Eltit; Roger A Bannister; Kai Liu; Isaac N Pessah; Kurt G Beam; Paul D Allen; José R López
Journal:  J Gen Physiol       Date:  2010-05-17       Impact factor: 4.086

4.  Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

5.  Voltage-dependent calcium release in human malignant hyperthermia muscle fibers.

Authors:  A Struk; F Lehmann-Horn; W Melzer
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

Review 6.  Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.

Authors:  Jörg Striessnig; Hanno Jörn Bolz; Alexandra Koschak
Journal:  Pflugers Arch       Date:  2010-03-07       Impact factor: 3.657

7.  Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all.

Authors:  Feliciano Protasi; Cecilia Paolini; Marta Canato; Carlo Reggiani; Marco Quarta
Journal:  J Muscle Res Cell Motil       Date:  2011-12-01       Impact factor: 2.698

8.  Voltage modulates halothane-triggered Ca2+ release in malignant hyperthermia-susceptible muscle.

Authors:  Alberto Zullo; Martin Textor; Philipp Elischer; Stefan Mall; Andreas Alt; Werner Klingler; Werner Melzer
Journal:  J Gen Physiol       Date:  2017-12-15       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.